A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
Document Type
Journal Article
Publication Date
4-25-2018
Journal
Pediatric Blood and Cancer
DOI
10.1002/pbc.27077
APA Citation
Chuk, M., Widemann, B., Minard, C., Liu, X., Kim, A., Bernhardt, M., Kudgus, R., Reid, J., Voss, S., Blaney, S., Fox, E., & Weigel, B. (2018). A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.. Pediatric Blood and Cancer, (). http://dx.doi.org/10.1002/pbc.27077
Peer Reviewed
1
